Name | KT185 |
---|
Description | KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC50 0.21 nM in Neuro2A cells[1]. |
---|---|
Related Catalog | |
Target |
IC50: ABHD6 (0.21 nM in Neuro2A cells)[1]. |
References |
Molecular Formula | C32H33N5O2 |
---|---|
Molecular Weight | 519.64 |
RIDADR | NONH for all modes of transport |
---|